Previous studies have shown that BRG1 is critical for the expression of CD44 in several cancer cells and demonstrated that CD44 expression is induced by the demethylating agent 5-aza in BRG1 deficient cancer cells [18, 19]. The gene discussed is SMARCA4; the disease is cancer.